Clinical Trial Update: Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer [NA]

View source ↗

Summary

This completed clinical trial evaluates the prognostic value of 18F-FMISO PET-CT in patients with head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Cancer of Head and Neck, Head and Neck Neoplasms | NA | Status: COMPLETED